IJDDP/
Articles

Articles

Open AccessReview

Myocardial Lipotoxicity in Cardiovascular Diseases: Mechanisms, Therapeutic Strategies, and Drug Target Discovery

Yaxin Xu, Xinrui Li, Lu Fu

2026, 5(2): 100009. doi: 10.53941/ijddp.2026.100009

1 Downloaded
8 Viewed
Download PDF
Open AccessReview

Nucleolus, Nucleolar Stress and Cardiovascular Diseases

Rongqian Xu, Xiaocen Jin, Yan Zhang, Xiaolei Yang, Yunlong Xia

2026, 5(1): 100002. doi: 10.53941/ijddp.2026.100002

43 Downloaded
194 Viewed
Download PDF
Open AccessReview

RhoA/ROCK Signaling in Vascular Dysfunction: Emerging Insights and Therapeutic Perspectives

Xiao Du, Weijia Luo, Jiang Chang

2025, 4(4): 100022. doi: 10.53941/ijddp.2025.100022

43 Downloaded
217 Viewed
1 Cited
Download PDF
Open AccessReview

Alkaloids and Their Mechanisms of Action in Cardiovascular Diseases

Anil Kumar Prajapati, Gaurang Shah

2025, 4(3): 100017. doi: 10.53941/ijddp.2025.100017

61 Downloaded
368 Viewed
Download PDF
Open AccessCommunication
Strategizing Cardiovascular Management in Diabetic Patients: Insights and Advancements from the 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

Hongyuan Zhang, Darren Green, Yanrong Liu

2025, 4(1): 100002. doi: 10.53941/ijddp.2025.100002

32 Downloaded
191 Viewed
Download PDF
Open AccessReview
Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4+Foxp3+ Regulatory T Cell Immunosuppression

Ying Shao, William Y. Yang, Gayani Nanayakkara, Fatma Saaoud, Mohammed Ben Issa, Keman Xu, Yifan Liu, Xiaohua Jiang, Sadia Mohsin, Hong Wang, Xiaofeng Yang

2024, 3(4): 100022. doi: 10.53941/ijddp.2024.100022

20 Downloaded
126 Viewed
5 Cited
Download PDF
Open AccessReview
Metabolomics in Cardiovascular Diseases

Shan Lu, Zisheng Huang, Baitao Liu, Yan Zhang

2024, 3(4): 100019. doi: 10.53941/ijddp.2024.100019

26 Downloaded
160 Viewed
Download PDF
Open AccessReview
Integrins as Drug Targets in Vascular and Related Diseases

Emily Meredith, Martin A. Schwartz

2024, 3(2): 100010. doi: 10.53941/ijddp.2024.100010

21 Downloaded
116 Viewed
2 Cited
Download PDF
Open AccessArticle
A Minimally Invasive Approach for Cardiac Electrophysiology Studies in Mice

Min Zi, Sabu Abraham, Alicia D'souza, David Hutchings, Sukhpal Prehar, Xin Wang, Elizabeth J Cartwright

2023, 2(1): 72-84. doi: 10.53941/ijddp.0201006

17 Downloaded
92 Viewed
Download PDF
Open AccessReview
The Therapeutic Effects of Ligustrazine in Combination with Other Drugs in Cardiovascular Diseases

Peihua Dong, Yu Huang, Yujie Pu

2023, 2(1): 11-17. doi: 10.53941/ijddp.0201005

11 Downloaded
89 Viewed
Download PDF
Open AccessReview
Is miR-21 A Therapeutic Target in Cardiovascular Disease?

Antoinette Holland, Molly Enrick, Arianna Diaz, Liya Yin

2023, 2(1): 26-36. doi: 10.53941/ijddp.0201003

17 Downloaded
94 Viewed
21 Cited
Download PDF
Open AccessReview
The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease

Honglin Xu, Dingwei Wang, Chiara Ramponi, Xin Wang, Hongyuan Zhang

2022, 1(1): 5. doi: 10.53941/ijddp.v1i1.179

17 Downloaded
132 Viewed
6 Cited
Download PDF
Open AccessReview
Cardiac β-Adrenoceptor Signaling: The New Insight on An Old Target in the Therapy of Cardiovascular Disease

Ying Song, Anthony Yiu-Ho WOO, Yan Zhang, Ruiping Xiao

2022, 1(1): 3. doi: 10.53941/ijddp.v1i1.177

35 Downloaded
146 Viewed
Download PDF